Literature DB >> 15564464

Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.

Rachel A Garbitt1, Karen R Bone, Leslie J Parent.   

Abstract

The Rous sarcoma virus Gag protein undergoes transient nuclear trafficking during virus assembly. Nuclear import is mediated by a nuclear targeting sequence within the MA domain. To gain insight into the role of nuclear transport in replication, we investigated whether addition of a "classical " nuclear localization signal (NLS) in Gag would affect virus assembly or infectivity. A bipartite NLS derived from nucleoplasmin was inserted into a region of the MA domain of Gag that is dispensable for budding and infectivity. Gag proteins bearing the nucleoplasmin NLS insertion displayed an assembly defect. Mutant virus particles (RC.V8.NLS) were not infectious, although they were indistinguishable from wild-type virions in Gag, Gag-Pol, Env, and genomic RNA incorporation and Gag protein processing. Unexpectedly, postinfection viral DNA synthesis was also normal, as similar amounts of two-long-terminal-repeat junction molecules were detected for RC.V8.NLS and wild type, suggesting that the replication block occurred after nuclear entry of proviral DNA. Phenotypically revertant viruses arose after continued passage in culture, and sequence analysis revealed that the nucleoplasmin NLS coding sequence was deleted from the gag gene. To determine whether the nuclear targeting activity of the nucleoplasmin sequence was responsible for the infectivity defect, two critical basic amino acids in the NLS were altered. This virus (RC.V8.KR/AA) had restored infectivity, and the MA.KR/AA protein showed reduced nuclear localization, comparable to the wild-type MA protein. These data demonstrate that addition of a second NLS, which might direct MA and/or Gag into the nucleus by an alternate import pathway, is not compatible with productive virus infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564464      PMCID: PMC533892          DOI: 10.1128/JVI.78.24.13534-13542.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Transport of proteins and RNAs in and out of the nucleus.

Authors:  S Nakielny; G Dreyfuss
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

Review 2.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

Review 3.  Nucleocytoplasmic transport enters the atomic age.

Authors:  E Conti; E Izaurralde
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

4.  Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells.

Authors:  Z Parveen; A Krupetsky; M Engelstädter; K Cichutek; R J Pomerantz; R Dornburg
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

5.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs.

Authors:  K Melen; L Kinnunen; I Julkunen
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

7.  trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants.

Authors:  R A Garbitt; J A Albert; M D Kessler; L J Parent
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.

Authors:  T M Cairns; R C Craven
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein.

Authors:  E M Callahan; J W Wills
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Differential effects of C-terminal molecular tagged integrase on replication competent moloney murine leukemia virus.

Authors:  J A Seamon; M Adams; S Sengupta; M J Roth
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

View more
  8 in total

1.  Importin-beta family members mediate alpharetrovirus gag nuclear entry via interactions with matrix and nucleocapsid.

Authors:  Kristin L Butterfield-Gerson; Lisa Z Scheifele; Eileen P Ryan; Anita K Hopper; Leslie J Parent
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.

Authors:  Danso Ako-Adjei; Marc C Johnson; Volker M Vogt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

4.  Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.

Authors:  Rachel Garbitt-Hirst; Scott P Kenney; Leslie J Parent
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

Review 5.  Nuclear trafficking of retroviral RNAs and Gag proteins during late steps of replication.

Authors:  Matthew S Stake; Darrin V Bann; Rebecca J Kaddis; Leslie J Parent
Journal:  Viruses       Date:  2013-11-18       Impact factor: 5.048

6.  Visualizing Rous Sarcoma Virus Genomic RNA Dimerization in the Nucleus, Cytoplasm, and at the Plasma Membrane.

Authors:  Eunice C Chen; Rebecca J Kaddis Maldonado; Leslie J Parent
Journal:  Viruses       Date:  2021-05-13       Impact factor: 5.048

7.  An Infectious Rous Sarcoma Virus Gag Mutant That Is Defective in Nuclear Cycling.

Authors:  Clifton L Ricaña; Marc C Johnson
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

8.  RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA.

Authors:  Breanna L Rice; Timothy L Lochmann; Leslie J Parent
Journal:  Viruses       Date:  2020-03-27       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.